| Alton Spurgeon, OTR,L | |
|
6709 Chevigny St, Anchorage, AK 99502-2035 | |
| (907) 248-5641 | |
| Not Available |
| Full Name | Alton Spurgeon |
|---|---|
| Gender | Male |
| Speciality | Occupational Therapist |
| Location | 6709 Chevigny St, Anchorage, Alaska |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1174734651 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 225X00000X | Occupational Therapist | 490 (Alaska) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Alton Spurgeon, OTR,L 6709 Chevigny St, Anchorage, AK 99502-2035 Ph: (907) 248-5641 | Alton Spurgeon, OTR,L 6709 Chevigny St, Anchorage, AK 99502-2035 Ph: (907) 248-5641 |
News Archive
The drug Hydroxychloroquine has long been studied as a treatment for malaria and autoimmune diseases. When the coronavirus pandemic spread across the globe, many countries resorted to using the drug in the hopes that it would improve outcomes of hospitalized patients affected by the coronavirus disease (COVID-19).
Immunomedics, Inc., a biopharmaceutical company focused on developing monoclonal antibodies to treat cancer and other serious diseases, today announced the dosing of the first patient in a Phase I/II clinical trial of the doxorubicin conjugate of milatuzumab for the treatment of patients with relapsed multiple myeloma.
When the National Academy of Science's Institute of Medicine recently announced that Americans should exercise an hour a day to fight the country's growing obesity epidemic, collective groans could be heard in big cities and small towns everywhere.
NexMed, Inc., a specialty CRO with a pipeline of products based on the NexACT® technology, today announced that results from a pre-clinical study showed significant improvement in the delivery and half life of Å6, a proprietary peptide treatment for ovarian cancer currently in Phase 2 development by Angstrom Pharmaceuticals. Specifically, the incorporation of NexACT® enabled the dose of Å6 to be cut by half, or from twice per day to once per day delivered subcutaneously, while achieving the same level of efficacy in the mouse lung metastasis model.
› Verified 7 days ago
Paige N Thorne, MOTR/L Occupational Therapist Medicare: Medicare Enrolled Practice Location: 3831 Piper St Ste 220, Anchorage, AK 99508 Phone: 760-936-9766 | |
Forget Me Not Ot Llc Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 1048 W International Airport Rd, Suite 103, Anchorage, AK 99518 Phone: 907-317-5545 Fax: 907-865-2499 | |
Eva Cress Lyons, OTD Occupational Therapist Medicare: Accepting Medicare Assignments Practice Location: 3801 Lake Otis Pkwy, Anchorage, AK 99508 Phone: 907-562-2277 | |
Mrs. Stacey Marie Lord, OTR L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 8200 Homer Dr Ste F, Anchorage, AK 99518 Phone: 907-345-0050 Fax: 907-344-5103 | |
Ms. Tamara Dawn Moore, OTRL Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 600 W 41st Ave Ste 103, Anchorage, AK 99503 Phone: 907-306-1728 Fax: 907-334-9320 | |
Marie Koleka Swanson, Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 8200 Homer Dr Ste F, Anchorage, AK 99518 Phone: 907-345-0050 Fax: 907-344-5103 | |
Alexa Hanley, Occupational Therapist Medicare: Medicare Enrolled Practice Location: 9100 Centennial Cir, Anchorage, AK 99504 Phone: 907-333-8100 |